We are live on
!
Find out more
Assenagon Asset Management Portfolio holdings
AUM
$80.2B
1-Year Est. Return
50.57%
This Fund
S&P 500
This Quarter
Est. Return
+9.62%
1 Year Est. Return
+50.57%
3 Year Est. Return
+139.18%
5 Year Est. Return
+175.96%
10 Year Est. Return
–
AUM
$29.5B
AUM Growth
+$4.81B
(+20%)
Cap. Flow
+$2.82B
Cap. Flow
% of AUM
9.58%
Top 10 Holdings %
Top 10 Hldgs %
32.79%
Holding
1,495
New
316
Increased
416
Reduced
406
Closed
318
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$596M |
| 2 |
Apple
AAPL
|
+$461M |
| 3 |
Meta Platforms (Facebook)
META
|
+$411M |
| 4 |
Micron Technology
MU
|
+$296M |
| 5 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$245M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$361M |
| 2 |
Netflix
NFLX
|
+$303M |
| 3 |
ATVI
Activision Blizzard
ATVI
|
+$303M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$240M |
| 5 |
T-Mobile US
TMUS
|
+$233M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.78% |
| 2 | Consumer Discretionary | 14.1% |
| 3 | Communication Services | 12.23% |
| 4 | Healthcare | 10.23% |
| 5 | Financials | 7.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
XLRN
76
DELISTED
Acceleron Pharma
XLRN
| $72M | 0.24% |
573,802
+439,489
| +327% | +$55.4M |
|
|
B
77
Barrick Mining
B
$73.2B
| $70.9M | 0.24% |
3,430,180
+2,195,314
| +178% | +$49.5M |
|
78
Cadence Design Systems
CDNS
$93.4B
| $70.7M | 0.24% |
516,973
-90,181
| -15% | -$11.9M |
|
79
Salesforce
CRM
$158B
| $68.3M | 0.23% |
279,798
+16,708
| +6% | +$3.85M |
|
80
United Therapeutics
UTHR
$23.1B
| $68M | 0.23% |
378,956
+220,777
| +140% | +$42M |
|
|
COUP
81
DELISTED
Coupa Software Incorporated
COUP
| $67.9M | 0.23% |
258,990
+231,233
| +833% | +$57.3M |
|
82
Tapestry
TPR
$32.8B
| $67.6M | 0.23% |
1,554,736
-340,043
| -18% | -$15.2M |
|
83
CBRE Group
CBRE
$42.9B
| $67.6M | 0.23% |
788,149
+770,399
| +4,340% | +$65.8M |
|
|
84
PUT
Meta Platforms (Facebook)
META
$1.51T
| $66.8M | 0.23% |
192,000
+72,000
| +60% | +$23.1M |
|
85
Intuitive Surgical
ISRG
$134B
| $66.2M | 0.22% |
215,790
-62,469
| -22% | -$17.5M |
|
86
Ally Financial
ALLY
$13.3B
| $66.1M | 0.22% |
1,325,404
-784,191
| -37% | -$40.2M |
|
87
Freeport-McMoran
FCX
$97.5B
| $65.6M | 0.22% |
1,768,714
-1,950,910
| -52% | -$76M |
|
88
Advanced Micro Devices
AMD
$789B
| $64.1M | 0.22% |
682,190
+157,119
| +30% | +$12.7M |
|
89
RH
RH
$3.71B
| $61.9M | 0.21% |
+91,193
| New | +$59.2M |
|
90
Liberty Broadband Class C
LBRDK
$5.15B
| $61.7M | 0.21% |
355,175
-20,962
| -6% | -$3.37M |
|
91
PUT
Oracle
ORCL
$423B
| $60.7M | 0.21% |
780,000
-30,000
| -4% | -$2.35M |
|
92
McKesson
MCK
$101B
| $60.4M | 0.2% |
+315,578
| New | +$61M |
|
93
Johnson & Johnson
JNJ
$625B
| $60M | 0.2% |
364,471
+139,861
| +62% | +$23.2M |
|
94
Marriott International
MAR
$92.3B
| $59.5M | 0.2% |
435,949
+212,707
| +95% | +$30.7M |
|
|
MRTX
95
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $58.7M | 0.2% |
363,559
+72,021
| +25% | +$11.6M |
|
96
Churchill Downs
CHDN
$6.12B
| $58.4M | 0.2% |
+588,734
| New | +$60.5M |
|
97
PUT
MetLife
MET
$62.1B
| $57.5M | 0.2% |
960,000
+400,000
| +71% | +$25.4M |
|
98
CALL
Citigroup
C
$226B
| $57.3M | 0.19% |
810,000
-820,000
| -50% | -$60.7M |
|
99
ICICI Bank
IBN
$108B
| $57M | 0.19% |
3,333,480
-631,893
| -16% | -$10.5M |
|
100
XP
XP
$8.39B
| $57M | 0.19% |
+1,308,134
| New | +$54.1M |
|
Similar funds
Assenagon Asset Management's Q2 2021 Portfolio in Review
As of Q2 2021, Assenagon Asset Management held 1,495 positions worth $29.5B, up 20% from $24.6B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Assenagon Asset Management deployed $2.82B of net new capital in Q2 2021, opening 316 new positions and adding to 416 existing holdings. Its largest new stake was Alexion Pharmaceuticals: 1,426,193 shares worth $262M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was Walt Disney, an estimated $361M trimmed.
- Assenagon Asset Management's largest Q2 2021 buy was Alexion Pharmaceuticals: 1,426,193 shares worth $262M.
- Assenagon Asset Management added most to Amazon in Q2 2021, an estimated $596M increase.
- Assenagon Asset Management's biggest Q2 2021 reduction was Walt Disney, cutting an estimated $361M.
- Assenagon Asset Management fully exited INPHI CORPORATION in Q2 2021, selling an estimated $47.9M.
- Assenagon Asset Management's ten largest holdings make up 33% of its $29.5B portfolio in Q2 2021.
- Assenagon Asset Management opened 316 new positions and closed 318 in Q2 2021.
- Assenagon Asset Management's portfolio value rose 20% quarter-over-quarter to $29.5B.
Based on Assenagon Asset Management's 13F filing for Q2 2021, filed 15 Jul 2021.